Clinical Trials Directory

Trials / Conditions / Recurrent Cutaneous Melanoma

Recurrent Cutaneous Melanoma

6 registered clinical trials studyying Recurrent Cutaneous Melanoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingPersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positiv
NCT05098210
Fred Hutchinson Cancer CenterPhase 1
Active Not RecruitingA Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment i
NCT04708418
National Cancer Institute (NCI)Phase 2
TerminatedTesting Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement
NCT04221438
ECOG-ACRIN Cancer Research GroupPhase 2
TerminatedDonor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapse
NCT03420963
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingIbrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma
NCT02581930
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPhysician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizuma
NCT02506153
National Cancer Institute (NCI)Phase 3